Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer

Por Bhatia, Shailender, Afanasiev, Olga, Nghiem, Paul
Publicado em 2011

Treatment of Metastatic Melanoma: An Overview

Por BHATIA, SHAILENDER, TYKODI, SCOTT S., THOMPSON, JOHN A.
Publicado em 2009

Emerging and Mechanism-Based Therapies for Recurrent or Metastatic Merkel Cell Carcinoma

Por Miller, Natalie J., Bhatia, Shailender, Parvathaneni, Upendra, Iyer, Jayasri G., Nghiem, Paul
Publicado em 2013

Systemic therapy of brain metastases: non–small cell lung cancer, breast cancer, and melanoma

Por Chamberlain, Marc C., Baik, Christina S., Gadi, Vijayakrishna K., Bhatia, Shailender, Chow, Laura Q.M.
Publicado no Neuro Oncol (2017)

Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100)

Por Daud, Adil, Algazi, Alain, Ashworth, Michelle, Buljan, Michael, Takamura, Kathryn Toshimi, Diep, Tu, Pierce, Robert H, Bhatia, Shailender
Publicado no J Transl Med (2015)

Clinical Utility of a Circulating Tumor Cell Assay in Merkel cell carcinoma

Por Blom, Astrid, Bhatia, Shailender, Pietromonaco, Stephanie, Koehler, Karen, Iyer, Jayasri G., Nagase, Kotaro, Paulson, Kelly, Sabath, Daniel E., Nghiem, Paul
Publicado em 2013

Paraneoplastic syndromes associated with Merkel cell carcinoma: A case series of eight patients highlighting different clinical manifestations

Por Iyer, Jayasri, Parvathaneni, Kaushik, Bhatia, Shailender, Shantha, Erica, Blom, Astrid, Doumani, Ryan, McKenzie, Jill, Asgari, Maryam M., Nghiem, Paul
Publicado no J Am Acad Dermatol (2016)

Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512

Por Bhatia, Shailender, Moon, James, Margolin, Kim A., Weber, Jeffrey S., Lao, Christopher D., Othus, Megan, Aparicio, Ana M., Ribas, Antoni, Sondak, Vernon K.
Publicado em 2012

A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma

Por Bhatia, Shailender, Pavlick, Anna C., Boasberg, Peter, Thompson, John A., Mulligan, George, Pickard, Michael D., Faessel, Hélène, Dezube, Bruce J., Hamid, Omid
Publicado no Invest New Drugs (2016)

Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors

Por Shah, Manisha H., Lorigan, Paul, O’Brien, Mary E. R., Fossella, Frank V., Moore, Kathleen N., Bhatia, Shailender, Kirby, Maurice, Woll, Penella J.
Publicado no Invest New Drugs (2016)

Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma

Por Iyer, Jayasri G., Blom, Astrid, Doumani, Ryan, Lewis, Christopher, Tarabadkar, Erica S., Anderson, Austin, Ma, Christine, Bestick, Amy, Parvathaneni, Upendra, Bhatia, Shailender, Nghiem, Paul
Publicado no Cancer Med (2016)

Systemic immune suppression as a stage-independent predictor of diminished Merkel cell carcinoma-specific survival

Por Paulson, Kelly G., Iyer, Jayasri G., Blom, Astrid, Warton, E. Margaret, Sokil, Monica, Yelistratova, Lola, Schuman, Louise, Nagase, Kotaro, Bhatia, Shailender, Asgari, Maryam M., Nghiem, Paul
Publicado em 2012

Transferred melanoma-specific CD8(+) T cells persist, mediate tumor regression, and acquire central memory phenotype

Por Chapuis, Aude G., Thompson, John A., Margolin, Kim A., Rodmyre, Rebecca, Lai, Ivy P., Dowdy, Kaye, Farrar, Erik A., Bhatia, Shailender, Sabath, Daniel E., Cao, Jianhong, Li, Yongqing, Yee, Cassian
Publicado em 2012

Single-fraction radiation therapy in patients with metastatic Merkel cell carcinoma

Por Iyer, Jayasri G, Parvathaneni, Upendra, Gooley, Ted, Miller, Natalie J, Markowitz, Elan, Blom, Astrid, Lewis, Christopher W, Doumani, Ryan F, Parvathaneni, Kaushik, Anderson, Austin, Bestick, Amy, Liao, Jay, Kane, Gabrielle, Bhatia, Shailender, Paulson, Kelly, Nghiem, Paul
Publicado no Cancer Med (2015)

Combined IL-21–primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient

Por Chapuis, Aude G., Lee, Sylvia M., Thompson, John A., Roberts, Ilana M., Margolin, Kim A., Bhatia, Shailender, Sloan, Heather L., Lai, Ivy, Wagener, Felecia, Shibuya, Kendall, Cao, Jianhong, Wolchok, Jedd D., Greenberg, Philip D., Yee, Cassian
Publicado no J Exp Med (2016)

Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I

Por Chapuis, Aude G., Afanasiev, Olga K., Iyer, Jayasri G., Paulson, Kelly G., Parvathaneni, Upendra, Hwang, Joo Ha, Lai, Ivy, Roberts, Ilana M., Sloan, Heather L., Bhatia, Shailender, Shibuya, Kendall C., Gooley, Ted, Desmarais, Cindy, Koelle, David M., Yee, Cassian, Nghiem, Paul
Publicado em 2013

Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study

Por Bhatia, Shailender, Curti, Brendan, Ernstoff, Marc S, Gordon, Michael, Heath, Elisabeth I, Miller, Wilson H, Puzanov, Igor, Quinn, David I, Flaig, Thomas W, VanVeldhuizen, Peter, Byrnes-Blake, Kelly, Freeman, Jeremy A, Bittner, Rachel, Hunder, Naomi, Souza, Sonia, Thompson, John A
Publicado em 2014

Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: a prospective validation study

Por Paulson, Kelly G., Lewis, Christopher W., Redman, Mary W., Simonson, William T., Lisberg, Aaron, Ritter, Deborah, Morishima, Chihiro, Hutchinson, Kathy, Yelistratova, Lola, Blom, Astrid, Iyer, Jayasri, Moshiri, Ata S., Shantha, Erica, Carter, Joseph J., Bhatia, Shailender, Kawasumi, Masaoki, Galloway, Denise A., Wener, Mark H., Nghiem, Paul
Publicado no Cancer (2016)

A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC)

Por Pal, Sumanta, Azad, Arun, Bhatia, Shailender, Drabkin, Harry, Costello, Brian, Sarantopoulos, John, Kanesvaran, Ravindran, Lauer, Richard, Starodub, Alexander, Hauke, Ralph, Sweeney, Christopher J., Hahn, Noah M., Sonpavde, Guru, Richey, Stephen, Breen, Timothy, Kremmidiotis, Gabriel, Leske, Annabell, Doolin, Elizabeth, Bibby, David C., Simpson, Jeremy, Iglesias, Jose, Hutson, Thomas
Publicado no Clin Cancer Res (2015)

Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma

Por Paulson, Kelly G., Tegeder, Andrew, Willmes, Christoph, Iyer, Jayasri G, Afanasiev, Olga K., Schrama, David, Koba, Shinichi, Thibodeau, Renee, Nagase, Kotaro, Simonson, William T, Seo, Aaron, Koelle, David M., Madeleine, Margaret, Bhatia, Shailender, Nakajima, Hideki, Sano, Shigetoshi, Hardwick, James S., Disis, Mary L., Cleary, Michele A, Becker, Jürgen C., Nghiem, Paul
Publicado no Cancer Immunol Res (2014)